Part 2: When Should Bisphosphonates Be Used in Children with Chronic Illness Osteoporosis?

Leanne M Ward1,2

  • 1University of Ottawa, Ottawa, Canada. Lward@cheo.on.ca.

Insights

Many children with secondary osteoporosis can recover without medication. This review guides decisions on bisphosphonate therapy by assessing recovery potential and distinguishing fragility fractures from typical childhood breaks.

Area of Science:

  • Pediatric Endocrinology
  • Bone Metabolism
  • Pediatric Osteoporosis

Background:

  • Secondary osteoporosis in children requires careful management.
  • Distinguishing between primary and secondary osteoporosis is crucial for treatment decisions.

Purpose of the Study:

  • To guide the decision-making process for initiating bisphosphonate therapy in children with secondary osteoporosis.
  • To differentiate children who can achieve medication-unassisted recovery from those requiring intervention.

Main Methods:

  • Review of natural history studies on secondary osteoporosis in children.
  • Analysis of factors influencing bone recovery and vertebral reshaping.
  • Evaluation of criteria for identifying bone fragility versus typical childhood fractures.

Main Results:

  • Many children with secondary osteoporosis can recover fully without bisphosphonate therapy.
  • Recovery can range from deterioration to significant bone mineral density (BMD) improvement and vertebral restoration.
  • Vertebral reshaping is growth-dependent, necessitating timely intervention for at-risk children.

Conclusions:

  • The decision to use bisphosphonates hinges on assessing recovery potential and distinguishing fragility fractures.
  • Bone mineral density improvements and structural bone restitution are key indicators of recovery in pediatric osteoporosis.
  • Identifying children who require bisphosphonate therapy is critical to prevent permanent deformities.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.5K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
39.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
What is the Skeletal System?01:02

What is the Skeletal System?

Overview
54.8K